Piasclédine 300mg box of 90 capsules
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Free delivery for orders over 89€*.
* in metropolitan France and excluding drugs
Visco-elastic preparation:
Pre-filled luer-lock syringe, 3 ml, presented in an individual sterility protector, unit box (EAN 3700288621047).
pml | |
Sodium hyaluronate (FB) |
25mg |
Symptomatic treatment of gonarthrosis.
The viscoelastic device Arthrum Visc 75 Mono Injection is recommended for reducing pain and restoring joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in arthritic joints.
The therapeutic indications are all types of painful gonarthrosis:
Primary gonarthroses (radiological stages of kelgreen I, II and III).
Gonarthrosis and associated general factors: ineffectiveness of usual treatments, intolerance and or contraindication to NSAIDs and/or analgesics, use of anticoagulants, polymedication (hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems), contraindications linked to the fitting of a prosthesis (young subject) and various contraindications linked to the patient's condition.
Early gonarthrosis in young patients.
Gonarthrosis secondary to trauma and to the aftermath of joint fractures.
1 intra-articular injection in the knee. A second injection may be given between the first and third month if the patient's painful symptomatology justifies it.
Open the individual sterility protector aseptically.
Take the syringe aseptically.
Screw the injection needle onto the Luer lock after removing the tip-cap without touching the tip of the syringe with your finger.
Inject intra-articularly.
Single use. The syringe and needle must be disposed of immediately after use, in a specific single-use waste box.
Check the integrity of the individual sterility protector of the product before use.
Respect the rules of asepsis.
Do not inject other products at the same time as Arthrum Visc 75 Mono Injection.
The precautions for use are those required by the protocol used for intra-articular injections in rheumatology and orthopaedic surgery. The specialist physician remains responsible for his or her own techniques and indications.
Inform the patient that he/she must remain at rest for 24 hours and avoid all sports and/or professional activities.
For professional use only.
Do not inject intravascularly.
Do not inject outside the joint cavity or into the synovial tissue or capsule and/or in the presence of significant effusion.
Not studied in pregnant women.
Do not use quaternary ammonium (benzalkonium chloride) for skin disinfection during intra-articular injection of Arthrum Visc 75 Mono Injection.
Arthrum Visc 75 Mono Injection is well tolerated. Occasionally, pain may occur for 48 hours. It is recommended to apply an ice bladder for a few hours.
All inflammatory conditions of the joint that should be treated before treatment with Arthrum Visc 75 Mono Injection is initiated.
Do not administer if the patient has a known hypersensitivity to sodium hyaluronate.
Store before opening between + 2 °C and + 30 °C.
Protect from light and freezing.
After opening, the viscoelastic Arthrum Visc 75 Mono Injection must be used immediately and discarded after use.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.
SYNOVIUM HCS viscoelastic devices are indicated for the symptomatic treatment of gonarthrosis, in particular to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid in arthritic joints.
The therapeutic indications are all types of painful gonarthrosis:
- Primary gonarthrosis (Kelgreen radiological stages I, II and III)
- Gonarthrosis and associated general factors:
- Ineffectiveness of usual treatments.
- Intolerance and/or contraindication to NSAIDs and/or analgesics.
- Taking anticoagulants, poly-medication (hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems).
- Contraindications related to the fitting of a prosthesis: young patients and various contraindications related to the patient's condition.
- Early gonarthrosis in young patients.
- Gonarthrosis secondary to trauma and the aftermath of articular fractures.
The Alvita heating patch offers long-lasting relief from minor aches and pains, joint stiffness and muscle and joint pain.
Box of 4 patches, 13 cm x 9.5 cm
Long-lasting, targeted pain relief. Relieves pain for 8 hours.
Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.
Symptomatic treatment ofosteoarthritis.
Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.
Description: HYALEXO EXPANSCIENCE is a hyaluronic acid-based medical device indicated for the relief of pain in patients suffering fromosteoarthritis or degenerative joint diseases resulting in an alteration of the functional properties of synovial fluid.
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Indications: STRUCTUM is used in adults (over 15 years of age) for the treatment of pain and functional discomfort in osteoarthritis of the knee and hip. This drug has a slow onset of action, delayed by about 2 months, and its effect may persist after treatment has been stopped.
OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.
Indications: Phytostandard of harpagophytum and willow Pileje is a food supplement to improve joint comfort.
The extracts of harpagophytum and willow are obtained through the patented Phytostandard® process known for its respect for the integrity of the plant's compounds.
Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.
With its flagship active ingredients (CBD, Turmeric, Harpagophytum, Magnesium) Forté Flex Kiné CBD cream helps relieve and soothe muscle and joint pain.